Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Encorium Group, a full-service multinational contract research organization that provides design, development, and management capabilities for clinical trials and patient registries to pharmaceutical companies has signed multiple new contracts with an aggregate value of approximately $1.7 million.
Subscribe to our email newsletter
These contracts, which are with an international biotechnology company, cover regulatory submission services, support of new clinical trials, and changes-of-scope for existing studies. The therapeutic areas covered in these contracts are oncology and rheumatology.
Kenneth Borow, president and CEO of Encorium Group, said: “These trials in oncology and rheumatology focus on developing fully human antibody therapeutics for unmet medical needs. They represent important business opportunities for Encorium with a repeat client.”